Factors influencing men's interest in gene testing for prostate cancer susceptibility

Journal of Genetic Counseling

Volumn 11, Issue 5, 2002, Pages 383-398

  Culler, Duane D ^a   Silberg, Judy ^b   Vanner Nicely, Lauren ^b   Ware, Joy L ^b   Jackson Cook, Colleen ^b   Bodurtha, Joann ^b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Genetic testing; Men; Monitoring; Prostate cancer genes; Psychosocial issues

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; COST; DEMOGRAPHY; FAMILY HISTORY; GENE MUTATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HEALTH BEHAVIOR; HOSPITAL DEPARTMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT REFERRAL; PROSTATE CANCER; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; REVIEW; URBAN AREA;

EID: 21344468012     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1023/A:1016889614588     Document Type: Review

References (38)

1. Andrykowski MA, Munn RK, Studts JL (1996) Interest in learning of personal genetic risk for cancer: A general population survey. Prev Med 25:527-536.
2. Berthon P, Valeri A, Cohen-Akenine A, Drelon E, Paiss T, Wohr G, Latil A, Millasseau P, Mellah I, Cohen N, Blanche H, Bellance-Chantelot C, Demenais F, Teillac P, Le Duc A, de Petriconi R, Hautmann R, Chumakov I, Bachner L, Maitland NJ, Lidereau R, Vogel W, Fournier G, Mangin P, Cussenot O (1998) Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am J Hum Genet 62:1416-1424.
3. Bratt O, Kristoffersson U, Lundgren R, Olsson H (1997) Sons of men with prostate cancer: Their attitudes regarding possible inheritance of prostate cancer, screening and genetic testing. Urology 50:360-365.
4. Butow PN, Maclean M, Dunn SM, Tattersall MHN, Boyer MJ (1997) The dynamics of change: Cancer patients' preferences for information, involvement and support. Ann Oncol 8:857-863.
5. Christensen AG, Moran PH, Lawton WJ, Stallman D, Voigts AL (1997) Monitoring attentional style and medical regimen adherence in hemodialysis patients. Health Psychol 16:256-262.
6. Croyle RT, Lerman C (1993) Interest in genetic testing for colon cancer susceptibility: Cognitive and emotional correlates. Prev Med 22:284-292.
7. Durfy SJ, Bowen DJ, McTiernan A, Sproleder J, Burke W (1999) Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiol Biomarkers Prev 8:369-375.
8. Eysenck HJ, Eysenck SBG (1975) Manual of the Eysenck Personality Questionnaire. London: Hodder and Stoughton.
9. Geller G, Doksum T, Bernhart B, Metz SA (1999) Participation in breast cancer susceptibility testing protocols; influence of recruitment source, altruism, and family involvement in women's decisions. Cancer Epidemiol Biomarkers Prev 8:377-383.
10. Gibbs M, Stanford J, McIndoe R, Jarvik GP, Kolb S, Goode EL, Chakrabarti L, Schuster DR, Buckley VA, Miller EL, Brandzel S, Li S, Hood L, Ostrander EA (1999) Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am J Hum Genet 64:776-787.
11. Gronberg H, Isaacs SD, Smith JR, Carpten HD, Bova GS, Freije D, Xu H, Meyers DA, Collins FS, Trent JM, Walsh PC, Isaacs WB (1997) Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. JAMA 278:1251-1255.
12. Gronberg H, Xu J, Smith JR, Carpten JC, Isaacs SC, Freije D, Bova GS, Walsh PC, Collins FS, Trent JM, Meyers DA, Isaacs WB (1998) Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPCl) on chromosome 1. J Urol 160:265-266.
13. Johnson JD, Roberts CS, Cox CE, Reintgen DS, Levin JS, Parsons M (1996) Breast cancer patients' personality, age and treatment decision making. J Surg Oncol 63:183-186.
14. Lerman C, Audrain J, Croyle R (1994a) DNA-testing for heritable breast cancer risks: Lessons from traditional genetic counseling. Ann Behav Med 16:327-333.
15. Lerman C, Biesecker B, Benkendorf JL, Kerner J, Gomez-Caminero A, Hughes C, Reed M (1997a) Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst 89:148-157.
16. Lerman C, Daly M, Masny M, Balshem A (1994b) Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 12:843-850.
17. Lerman C, Marshall J, Audrain J, Gomes-Caminero A (1996a) Genetic testing for colon cancer susceptibility: Anticipated reactions of patients and challenges to providers. Int J Cancer 69:58-61.
18. Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, Godk K, Trock B, Main D, Lynch J, Fulmore C, Snyder C, Lemon SJ, Conway T, Tonin P, Lenoir G, Lynch H (1996b) BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective study of patient decision making and outcomes. JAMA 275:1885-1892.
19. Lerman C, Schwartz MD, Narod S, Lynch HT (1997b)The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol 65:414-420.
20. Lipkus IM, Iden D, Terrenoire J, Feaganes JR (1999) Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer. Cancer Epidemiol Biomarkers Prev 8:533-539.
21. Miesfeldt S, Jones S, Cohn W, Lippert M, Haden K, Turner BL, Martin-Fries T, Clark SM (2000) Men's attitudes regarding genetic testing for hereditary prostate cancer risk. Urology 55:46-50.
22. Miller SM (1987) Monitoring and blunting: Validation of a questionnaire to assess styles of information seeking under threat. J Pers Soc Psychol 52:345-353.
23. Miller SM (1990) To see or not to see: Cognitive informational styles in the coping process. In: Rosenbaum M (ed) Learned Resourcefulness: On Coping Skills, Self-Control and Adaptive Behavior. New York: Springer, pp 95-126.
24. Miller SM (1995) Monitoring versus blunting styles of coping with cancer influence the information patients want and need about their disease. Cancer 76:167-176.
25. Miller SM (1996) Monitoring and blunting of threatening information: Cognitive interference and facilitation in the coping process. In: Sarason IG, Pierce GR, Sarason BR (eds) Cognitive Interference: Theories, Models and Findings. Hillsdale, NJ: Erlbaum, pp 175-190.
26. Miller SM, Diefenbach MA (1998) The cognitive-social health information processing (C-SHIP) model: A theoretical framework for research in behavioral oncology. In: Krantz D (ed) Perspectives in Behavioral Medicine. Mahwah, NJ: Erlbaum.
27. Miller SM, Mangan CE (1983) The interacting effects of information and coping style in adapting to gynecological stress: Should the doctor tell all? J Pers Soc Psychol 45:223-236.
28. Miller SM, Rodoletz M, Schroeder CM, Mangam CE, Sedlacek TV (1996) Applications of the monitoring process model to coping with severe long-term medical threats. Health Psychol 15:216-225.
29. Rebbeck TR, Walker AH, Zeigler-Johnson C, Weisberg S, Martin A-M, Nathanson KL, Wein AJ, Malkowicz SB (2001) Association of HPC2/ELAC2 genotypes and prostate cancer. Am J Hum Genet 67:1014-1019.
30. Schneider KA, Marnane D (1997) Cancer risk counseling: How is it different? J Genet Couns 6:97-109.
31. Schwartz MD, Lerman C, Miller SM, Daly M, Masny A (1995) Coping disposition, perceived risk and psychological distress among women at increased risk for ovarian cancer. Health Psychol 14:232-235.
32. Smith KR, Croyle RT (1995) Attitudes toward genetic testing for colon cancer risk. Am J Public Health 85:1435-1438.
33. Smith J, Freije D, Carpten J, Gronberg H, Xu J, Isaacs S, Brownstein M, Bova G, Guo H, Bujnovszky P, Nusskern D, Damber J, Bergh A, Emanuelsson M, Kallioniemi O, Walker-Daniels J, Bailey-Wilson J, Beaty T, Meyers D, Walsh P, Collins F, Trent J, Isaacs W (1996) Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. JAMA 274:1371-1374.
34. Snedecor GW, Cochran WG (1967) Statistical Methods. Ames, IA: Iowa State University Press.
35. Stiggelbout AM, Kiebert GM (1997) A role for the sick role: Patient preferences regarding information and participation in clinical decision-making. Can Med Assoc J 157:383-389.
36. Tambor ES, Rimer BK, Strigo TS (1997) Genetic testing for breast cancer susceptibility: Awareness and interest among women in the general population. Am J Med Genet 68:43-49.
37. Tavtigian SV, Simard J, Teng CH, Abtin V, Baumgard M, Beck A, Camp NJ, Carillo AR, Chen Y, Dayananth P, Desrochers M, Dumont M, Farnham JM, Frank T, Frye C, Ghaffari S, Gupte JS, Hu R, Iliev D, Hanecki T, Kort EN, Laity KE, Leavitt A, Leblanc G, McArthur-Morrison J, Peterson A, Penn B, Peterson KT, Reid JE, Richards S, Schroeder M, Smith R, Snyder SC, Swedlund B, Swensen J, Thomas A, Tranchant M, Woodland AM, Labrie F, Skolnick MH, Neuhausen S, Rommens J, Cannon-Albright LA (2001) A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet 27:172-180.
38. Xu J, Meyers D, Freije D, Isaacs S, Wiley K, Nusskern D, Ewing C, Wilkens ED, Bujvszky P, Bova GS, Walsh P, Isaacs W, Schleutker J, Matikainen M, Tammela T, Visakorpi T, Kallioniemi OP, Berry R, Schaid D, French A, McDonnel S, Schroeder J, Blute M, Thibodeau S, Trent J (1998) Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 20:175-179.